Showing results (111-120 of 127) with videos related to
Sort By:
Pageof 13
Journal of Diabetes Investigation|May 17, 2016
Body mass index and the risk of cancer incidence in patients with type 2 diabetes in Japan: Results from the National Center Diabetes DatabaseRitsuko Yamamoto-Honda, Yoshihiko Takahashi, Yoko Yoshida, et al.Atherosclerosis|November 24, 2012
Effects of pitavastatin and atorvastatin on lipoprotein oxidation biomarkers in patients with dyslipidemiaHiroshi Yoshida, Toru Shoda, Hidekatsu Yanai, et al.Atherosclerosis|March 8, 2002
Unique character and metabolism of high density lipoprotein (HDL) in fetusHironori Nagasaka, Hitoshi Chiba, Hideaki Kikuta, et al.Lipids in Health and Disease|May 20, 2008
Characteristic comparison of triglyceride-rich remnant lipoprotein measurement between a new homogenous assay (RemL-C) and a conventional immunoseparation method (RLP-C)Hiroshi Yoshida, Hideo Kurosawa, Yuji Hirowatari, et al.Medicine|January 19, 2017
Development of diabetes mellitus associated with quetiapine: A case seriesHideki Nanasawa, Akahito Sako, Tomohiko Mitsutsuka, et al.Journal of Clinical Medicine Research|June 15, 2017
Effects of Six Kinds of Sodium-Glucose Cotransporter 2 Inhibitors on Metabolic Parameters, and Summarized Effect and Its Correlations With Baseline DataHidekatsu Yanai, Mariko Hakoshima, Hiroki Adachi, et al.The Journal of Pediatrics|March 10, 2005
Evaluation of risk for atherosclerosis in Alagille syndrome and progressive familial intrahepatic cholestasis: two congenital cholestatic diseases with different lipoprotein metabolismsHironori Nagasaka, Tohru Yorifuji, Hiroto Egawa, et al.Metabolism: Clinical and Experimental|October 16, 2010
CD36 deficiency predisposing young children to fasting hypoglycemiaHironori Nagasaka, Tohru Yorifuji, Tomozumi Takatani, et al.Journal of Atherosclerosis and Thrombosis|September 6, 2019
Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese IndividualsHiroshi Yoshida, Hayato Tada, Kumie Ito, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 11, 2023
Effects of sodium glucose cotransporter 2 inhibitors and pioglitazone on FIB-4 index in metabolic-associated fatty liver diseaseMasaaki Mino, Eiji Kakazu, Akitoshi Sano, et al.Pageof 13